| MeSH term | MeSH ID | Detail |
|---|---|---|
| Stomach Ulcer | D013276 | 75 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Atherosclerosis | D050197 | 85 associated lipids |
| Diabetes Mellitus, Experimental | D003921 | 85 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Seizures | D012640 | 87 associated lipids |
| Diabetes Mellitus, Type 2 | D003924 | 87 associated lipids |
| Brain Ischemia | D002545 | 89 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Hypercholesterolemia | D006937 | 91 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Kreuter A et al. | 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study. | 2006 | Arch Dermatol | pmid:16983001 |
| Stern RS | Topical calcineurin inhibitors labeling: putting the "box" in perspective. | 2006 | Arch Dermatol | pmid:16983018 |
| Travis LB et al. | Successful treatment of vitiligo with 0.1% tacrolimus ointment. | 2003 | Arch Dermatol | pmid:12756092 |
| Lepe V et al. | A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo. | 2003 | Arch Dermatol | pmid:12756094 |
| Plettenberg H et al. | Childhood vitiligo and tacrolimus: immunomodulating treatment for an autoimmune disease. | 2003 | Arch Dermatol | pmid:12756103 |
| Lübbe J et al. | Adults with atopic dermatitis and herpes simplex and topical therapy with tacrolimus: what kind of prevention? | 2003 | Arch Dermatol | pmid:12756112 |
| Bakos L and Bakos RM | Focal acne during topical tacrolimus therapy for vitiligo. | 2007 | Arch Dermatol | pmid:17875902 |
| Ruzicka T et al. | Tacrolimus: the drug for the turn of the millennium? | 1999 | Arch Dermatol | pmid:10328199 |
| Allen A et al. | Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. | 2001 | Arch Dermatol | pmid:11405764 |
| Qureshi AA and Fischer MA | Topical calcineurin inhibitors for atopic dermatitis: balancing clinical benefit and possible risks. | 2006 | Arch Dermatol | pmid:16702502 |
| Eichenfield LF et al. | 1% pimecrolimus cream for atopic dermatitis. | 2003 | Arch Dermatol | pmid:14568846 |
| Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group. | 1996 | Arch Dermatol | pmid:8629845 | |
| Firooz A et al. | Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial. | 2006 | Arch Dermatol | pmid:16924062 |
| Bigby M | A thorough systematic review of treatments for atopic eczema. | 2001 | Arch Dermatol | pmid:11735714 |
| Bernard LA et al. | A rosacea-like granulomatous eruption in a patient using tacrolimus ointment for atopic dermatitis. | 2003 | Arch Dermatol | pmid:12588240 |
| Zonneveld IM et al. | Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study. | 1998 | Arch Dermatol | pmid:9762021 |
| Jegasothy BV et al. | Tacrolimus (FK 506)--a new therapeutic agent for severe recalcitrant psoriasis. | 1992 | Arch Dermatol | pmid:1376102 |
| Van Leent EJ et al. | Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis. | 1998 | Arch Dermatol | pmid:9681343 |
| Mandelin J et al. | Effect of oral acetylsalicylic acid on burning caused by tacrolimus ointment in patients with atopic dermatitis. | 2010 | Arch Dermatol | pmid:20956662 |
| Lener EV et al. | Successful treatment of erosive lichen planus with topical tacrolimus. | 2001 | Arch Dermatol | pmid:11295919 |
| Mehrabi D and Pandya AG | A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B Plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo. | 2006 | Arch Dermatol | pmid:16847214 |
| Colebunders R et al. | HIV eosinophilic folliculitis in Uganda. | 2006 | Arch Dermatol | pmid:16847219 |
| Passeron T et al. | Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo. | 2004 | Arch Dermatol | pmid:15381545 |
| Bunker CB et al. | Topical tacrolimus, genital lichen sclerosus, and risk of squamous cell carcinoma. | 2004 | Arch Dermatol | pmid:15381566 |
| Pomerantz RG et al. | Posttransplant cutaneous T-cell lymphoma: case reports and review of the association of calcineurin inhibitor use with posttransplant lymphoproliferative disease risk. | 2010 | Arch Dermatol | pmid:20479299 |
| Ehst BD and Warshaw EM | Alcohol-induced application site erythema after topical immunomodulator use and its inhibition by aspirin. | 2004 | Arch Dermatol | pmid:15313828 |
| Sand C and Thomsen HK | Topical tacrolimus ointment is an effective therapy for Hailey-Hailey disease. | 2003 | Arch Dermatol | pmid:14623698 |
| Sagransky MJ et al. | A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. | 2010 | Arch Dermatol | pmid:21173330 |
| Laino L and DiCarlo A | Palmoplantar pustular psoriasis: clinical and video thermographic evaluation before and after topical tacrolimus treatment. | 2011 | Arch Dermatol | pmid:21690553 |
| Eiling E et al. | Pimecrolimus: a novel treatment for cetuximab-induced papulopustular eruption. | 2008 | Arch Dermatol | pmid:18794482 |
| Byrd JA et al. | Response of oral lichen planus to topical tacrolimus in 37 patients. | 2004 | Arch Dermatol | pmid:15611431 |
| Santos-Juanes J et al. | Topical tacrolimus: an effective therapy for Zoon balanitis. | 2004 | Arch Dermatol | pmid:15611442 |
| Milingou M et al. | Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. | 2004 | Arch Dermatol | pmid:15611445 |
| Carroll CL et al. | Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. | 2005 | Arch Dermatol | pmid:15655140 |
| Patel RR et al. | The safety and efficacy of tacrolimus therapy in patients younger than 2 years with atopic dermatitis. | 2003 | Arch Dermatol | pmid:12975161 |
| Nagao K et al. | A case of generalized pustular psoriasis treated with topical tacrolimus. | 2003 | Arch Dermatol | pmid:12975175 |
| Yan AC et al. | The safety and efficacy of pimecrolimus, 1%, cream for the treatment of Netherton syndrome: results from an exploratory study. | 2010 | Arch Dermatol | pmid:20083693 |
| Ciurea AM et al. | Complete and durable clinical response of malignant pyoderma to tacrolimus in combination with dapsone and prednisone. | 2010 | Arch Dermatol | pmid:20083712 |
| Castelo-Soccio L et al. | Induced lentiginosis with use of topical calcineurin inhibitors. | 2012 | Arch Dermatol | pmid:22710469 |
| Mikhail M et al. | Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus. | 2008 | Arch Dermatol | pmid:18427063 |
| Toutous-Trellu L et al. | Topical tacrolimus for effective treatment of eosinophilic folliculitis associated with human immunodeficiency virus infection. | 2005 | Arch Dermatol | pmid:16230556 |
| Kunstfeld R et al. | Successful treatment of vulvar lichen sclerosus with topical tacrolimus. | 2003 | Arch Dermatol | pmid:12873877 |
| Böhm M et al. | Successful treatment of anogenital lichen sclerosus with topical tacrolimus. | 2003 | Arch Dermatol | pmid:12873890 |
| Reitamo S et al. | Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis. The European Tacrolimus Ointment Study Group. | 2000 | Arch Dermatol | pmid:10926735 |
| Sugiura H et al. | Long-term efficacy of tacrolimus ointment for recalcitrant facial erythema resistant to topical corticosteroids in adult patients with atopic dermatitis. | 2000 | Arch Dermatol | pmid:10926750 |
| Byrd JA et al. | Recalcitrant symptomatic vulvar lichen planus: response to topical tacrolimus. | 2004 | Arch Dermatol | pmid:15210463 |
| Carroll PB et al. | Effect of tacrolimus (FK506) in dystrophic epidermolysis bullosa: rationale and preliminary results. | 1994 | Arch Dermatol | pmid:7526802 |
| Rapaport MJ | Topical tacrolimus. | 2005 | Arch Dermatol | pmid:16301404 |
| Mackelfresh J et al. | Combination therapy of doxycycline and topical tacrolimus for venous ulcers. | 2005 | Arch Dermatol | pmid:16301410 |
| Allen DM and Esterly NB | Significant systemic absorption of tacrolimus after topical application in a patient with lamellar ichthyosis. | 2002 | Arch Dermatol | pmid:12225004 |